GBS Inc.

    Jurisdiction
    United States
    ISIN
    US36151G1058 (GBS)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €2.62M
    Gross margin
    40.8%
    EBIT
    -€9.13M
    EBIT margin
    -348.7%
    Net income
    -€9.07M
    Net margin
    -346.2%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Other Sales €578.64K 22.1%

    Earnings Calls

    Latest earnings call: September 1, 2022

    Add to watchlist

    Notifications